Superficial Venous Thrombosis of Leg, Secondary Prevention

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Superficial Venous Thrombosis of Leg, Secondary Prevention trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT03428711

Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

The objective of the study is to demonstrate the superiority of the mesoglycan (Prisma®), compared to placebo, in reducing the incidence of thromboembolic compl…

Italy560 participantsStarted 2018-03-26

Treatment: Mesoglycan Oral Tablet, Placebo Oral Tablet